Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy | MicrobiomeTrials← Back to trialsNCT07715903
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-10-29Est. Completion: 2029-12-31
Enrollment target: 20 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Breast CancerDiabetesColon CancerCardiovascular Disease
This study will examine what methods work best for encouraging Mexican-American family members to talk about their risk …
Houston, United States
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinomaBile Duct CancerPancreas Cancer
Background:
\- Recent advances in cancer research have led to new therapies to treat the disease. It is important to co…
Bethesda, United StatesEst. completion Jun 30, 2035